Research ArticleTechnology/Application
A Model of Prefilled Syringes Exposure to Vapor Phase Hydrogen Peroxide (VPHP)
Dawn Downey, Bernard McGarvey, Michael Walsh and Jimmy Engle
PDA Journal of Pharmaceutical Science and Technology January 2020, 74 (1) 73-89; DOI: https://doi.org/10.5731/pdajpst.2018.009431
Dawn Downey
1Eli Lilly & Company, Pharmaceutical Engineering Technology Center, Lilly Technology Center, 1555 S. Harding Street, Indianapolis, IN 46221; and
Bernard McGarvey
1Eli Lilly & Company, Pharmaceutical Engineering Technology Center, Lilly Technology Center, 1555 S. Harding Street, Indianapolis, IN 46221; and
Michael Walsh
2Eli Lilly & Company, Global Quality Laboratories, Lilly Technology Center, 1555 S. Harding Street, Indianapolis, IN 46221
Jimmy Engle
2Eli Lilly & Company, Global Quality Laboratories, Lilly Technology Center, 1555 S. Harding Street, Indianapolis, IN 46221
Reference
- 1.↵
- Basmadjian D.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 74, Issue 1
January/February 2020
A Model of Prefilled Syringes Exposure to Vapor Phase Hydrogen Peroxide (VPHP)
Dawn Downey, Bernard McGarvey, Michael Walsh, Jimmy Engle
PDA Journal of Pharmaceutical Science and Technology Jan 2020, 74 (1) 73-89; DOI: 10.5731/pdajpst.2018.009431
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.